Lilly signs $1.3B deal with Boston startup for AI-assisted drug development

Please subscribe to IBJ to decode this article.

e cs.u$tr ebylr ia uoalMtn iesiicslelw etat sifn oCpaow lhlendeidld-rSl sbiieuaobnt slcher ouilo a1Ledtnota en3 isg tosnieiomuBTro- Eleco erib dbaotogsralcn iiu lmanlontdiasi g trldedic aclydrn phn avca.neougslim anunce m f re.sid yoimoeta

llace aollnp uclprsdlnu rplmanmletsimtiliex- orodLaorpe sa drteani u iareaophe y -d’pneiatt unnl lbi’ewiesomwlgszee iydadpleeechsinoreltovloa bwenactllI otbr lodmd nm iterasaellcsduae emsvl oneiud .fvaeSyoa dadm li,opd dnoiiseApym nmSoaccieIIs vpurrie r

0e "cofhteilasnhh-ya,dbweD gnttt p- fimeeg enimsdiassnstcttocderj,d>huoteliaao/hr=t baa n/ aaa foimnltos/rLei..g.enwkn-.gterwteaspl arou3ua .wi ntd uinlcoyei hs gds -tertrs-ieidwd.1rmicfcw -tlsnete r2p ni egupni sa fen4 u< rwme-vlhb t cqsot 2mf aohdaiZ eaegotf3Ugmesimo v ia aiscorsngydinnnmAe"cer rw,p scbo/ltul%roeasr:ywm ooe lh eeee2

oemusorngtreotg mv n aoinielosllm.,eoerysn iallge i akolte tectlmdF,einxfmelroloxagac e h hsL tinptmtper i srsntetif yy ocnl s l

.em dntlrtt oai nsnsooohsrepudsit oo, tgployioo,hsegiismu cie bcp v sdew Sm ieicyi sl-Afelorr tlvzpm itaraGRb not-kscret vwsrtotanec,ulamnlenei LpInICesr eam rrledestaaaa ip etnd c hou ueimudhrrs-tlwolmyiealGiefetac P tsndh i e eedle

s itltio“io.tppz,g ti,tiyo ethhtaanpi tltiethc int neadul e dtogiotnRn thr upLdntrebnnCn iiiel wroaic ”tga gcrls ta alilue erbdedt goolf tCrobtdtooamS dawih nblie.Pao’aaesdaoeege anentt Th-Dalpeae nr dmru ss cndrmin,icliv o amnao yti rg er fentrGu wetltisavullc meenCr nirChraoies t emoaoagd m l llfndn“qla at mipe dosecyi-ansseaOfa borreSlruwruaneeosmtmsmyeE areroaOdotu nshtw egietx idfgv u”ee

oanr lflrht hcdu id t atlya.eL hmay Jd Fnl nnecewrimroreletetcbocdnoo InBieeyio obh

vnal asefotneeredtsi fnlnenlreddtuebyapeg eixe niitneoai.luetoveao e on v . e pvad1 iarcme mnrr Si nalsps yitp ioldenril ieicm i epf ce tcoebse eig leand ,odnaemvlvLhegldm eiettrsl.ueotssol ta roiie ot haumdpii ietutactc eqdmilv uing r nmlpm lhul cmrrnsasu-reoseneri3iecomaplnaaeyd lS$stncterad ii sfo-dnnriluoonly,i rtsz reettelaiemmrlrrdptn,ucdeoloec tapmvbmcsei tntee

osLtio oclca GLlwitstw yalnitLauaease p dsg nbruyaieilphls paaeosa o ce gnn.Lt normslt yaiev bea i.BGm hiima. aesit to yelpdne aaslntomsrioiusSieasLras lobesyb t nli tclis ei pl ny Titmnoni

c nm-iolxpe a amaiirIisrsndo )dortrn ao:h-jiclEl-Msuc-aifgAhv/wiEi/teixuhnofa/ketp>uoleboeswDen orpm.c P nsa lnl(le5 isc =s ie/"eLcoiowe ofi ibwtEitdnne tl f -lPbeh- roimlnh.me ueydyn/oatrys-loetdl srsl Rl -vntdeldoniri ytnceca Lglol4rll"nL .rpn5ae ys itsderdenAlrc loLmLo fbb c oyteso4l.Pdliitnnluc’$ic

t.r 2ars,j6t%ebaan, um 9wruiepa n -il k$touse e9 g tlsit anyreh deu6 pma r.L rd